{"id":"https://openalex.org/W1922322992","doi":null,"title":"Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.","display_name":"Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W1922322992","mag":"1922322992","pmid":"https://pubmed.ncbi.nlm.nih.gov/11232749"},"language":"en","primary_location":{"id":"pmid:11232749","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11232749","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002615049","display_name":"Martin R.K Dossenbach","orcid":"https://orcid.org/0009-0006-6128-4002","observed_orcids":["https://orcid.org/0009-0006-6128-4002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M R Dossenbach","raw_affiliation_strings":["Lilly Area Medical Center Vienna, Austria. martin_dossenbach@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Area Medical Center Vienna, Austria. martin_dossenbach@lilly.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055489452","display_name":"P Kratky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Kratky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017139630","display_name":"Michael Schneidman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Schneidman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011054933","display_name":"Starr L. Grundy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S L Grundy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040108049","display_name":"Stephen Metcalfe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Metcalfe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109214489","display_name":"Gary D. Tollefson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G D Tollefson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072343139","display_name":"Robert Haim Belmaker","orcid":"https://orcid.org/0000-0001-9734-1829","observed_orcids":["https://orcid.org/0000-0001-9734-1829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R H Belmaker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0384,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.85392972,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"62 Suppl 2","issue":null,"first_page":"28","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9779999852180481},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8420000076293945},{"id":"https://openalex.org/keywords/treatment-non-response","display_name":"treatment non-response","score":0.671999990940094},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8159999847412109},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.7039999961853027},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7620000243186951},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8894091844558716},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.874886155128479},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.664421021938324},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6436406373977661},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5828680992126465},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5667375922203064},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.48244816064834595},{"id":"https://openalex.org/C123273963","wikidata":"https://www.wikidata.org/wiki/Q624758","display_name":"Psychopathology","level":2,"score":0.4580809473991394},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4481734335422516},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4297918379306793},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.4118790030479431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3803495764732361},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.34479886293411255},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.30444425344467163},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.12945041060447693},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010054","descriptor_name":"Brief Psychiatric Rating Scale","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11232749","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11232749","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},{"id":"mag:1922322992","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11232749","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W122505910","https://openalex.org/W1787454655","https://openalex.org/W1983133139","https://openalex.org/W2018434135","https://openalex.org/W2020844317","https://openalex.org/W2038901045","https://openalex.org/W2040538157","https://openalex.org/W2070735132","https://openalex.org/W3090293687"],"related_works":["https://openalex.org/W2067892283","https://openalex.org/W2058613872","https://openalex.org/W2004195687","https://openalex.org/W2000623703","https://openalex.org/W2039163742","https://openalex.org/W2094817135","https://openalex.org/W2059686805","https://openalex.org/W2016849258","https://openalex.org/W2005569406","https://openalex.org/W2019942044"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"multicenter,":[2],"open-label":[3,280],"study":[4,281],"evaluated":[5],"the":[6,62,110,135,143,170,189,198,238,302,305,311],"efficacy":[7,91,232],"and":[8,43,65,100,141,212,221],"safety":[9],"of":[10,25,29,38,73,82,87,114,162,175,209,278],"olanzapine":[11,163,284],"in":[12,98,181,215],"patients":[13,40,50,58,67,167,186,239,292],"with":[14,41,246,257],"schizophrenia":[15,45],"who":[16,187,240,248,293],"had":[17,194],"been":[18],"nonresponsive":[19,52,242,295],"or":[20,177],"intolerant":[21,60,250,297],"to":[22,53,61,84,95,243,251,263,273,298],"a":[23,79,171,206],"course":[24],"risperidone":[26,30,55,63,244,299],"(mean":[27,123],"duration":[28],"treatment":[31],"=":[32,128,178],"46.3":[33],"days).":[34],"METHOD:":[35],"A":[36],"total":[37,183],"34":[39],"DSM-III-R":[42],"ICD-9":[44],"entered":[46],"this":[47,279],"trial.":[48],"Twenty-five":[49],"were":[51,59,76,153,228,241,249],"previous":[54],"treatment,":[56,64],"6":[57],"3":[66],"listed":[68],"both":[69],"reasons":[70],"for":[71,290],"discontinuation":[72],"risperidone.":[74,252],"Patients":[75],"treated":[77],"across":[78,205],"dose":[80],"range":[81,208],"5":[83],"25":[85],"mg/day":[86],"olanzapine.":[88,274],"The":[89,276],"primary":[90],"variable":[92],"was":[93,107,132,254],"baseline":[94,120,156],"endpoint":[96,145],"change":[97],"Positive":[99],"Negative":[101],"Syndrome":[102],"Scale":[103],"(PANSS)":[104],"score.":[105,184],"Safety":[106],"assessed":[108],"using":[109],"Clinical":[111],"Global":[112],"Impressions-Severity":[113],"Illness":[115],"scale.":[116],"RESULTS:":[117],"Improvement":[118],"from":[119,155],"PANSS":[121,126,182,216],"score":[122,127],"+/-":[124,130,139,147],"SD":[125],"119.4":[129],"26.9)":[131],"evident":[133],"at":[134,142,234],"week-6":[136],"midpoint":[137],"(-22.2":[138],"19.5)":[140],"week-14":[144],"(-28.7":[146],"22.3).":[148],"On":[149],"average,":[150],"severity":[151],"ratings":[152],"reduced":[154],"by":[157,197],"25%":[158],"after":[159],"14":[160],"weeks":[161],"therapy.":[164],"Twenty":[165],"olanzapine-treated":[166],"(58.8%)":[168],"achieved":[169],"priori-defined":[172],"response":[173,190],"criterion":[174],">":[176],"20%":[179],"reduction":[180],"Among":[185],"met":[188],"criterion,":[191],"50%":[192],"(10/20)":[193],"done":[195],"so":[196],"fourth":[199],"week.":[200],"These":[201],"clinical":[202],"improvements":[203],"occurred":[204],"broad":[207],"symptom":[210],"domains":[211],"included":[213],"reductions":[214],"positive,":[217],"negative,":[218],"general":[219],"psychopathology,":[220],"mood":[222],"subscores.":[223],"No":[224],"statistically":[225],"significant":[226],"differences":[227],"found":[229],"on":[230],"any":[231,235],"measure":[233],"visit":[236],"between":[237],"compared":[245],"those":[247],"Olanzapine":[253],"well":[255],"tolerated,":[256],"no":[258],"subject":[259],"discontinuing":[260],"early":[261],"owing":[262],"an":[264,287],"intolerable":[265],"adverse":[266],"event":[267],"that":[268,283,308],"could":[269],"be":[270,286],"conclusively":[271],"linked":[272],"CONCLUSION:":[275],"results":[277,303],"suggest":[282],"may":[285],"effective":[288],"alternative":[289],"schizophrenic":[291],"are":[294],"and/or":[296],"treatment.":[300],"Moreover,":[301],"underscore":[304],"differential":[306],"pharmacology":[307],"exists":[309],"among":[310],"newer":[312],"antipsychotic":[313],"agents.":[314]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}